| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.003 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.003 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.003 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.003 |